Literature DB >> 12578153

Diagnostic tools in respiratory tract infections: use and comparison with Finnish guidelines.

Pekka Olavi Honkanen1, Ulla-Maija Rautakorpi, Pentti Huovinen, Timo Klaukka, Erkki Palva, Risto Roine, Hannu Sarkkinen, Helena Varonen, Marjukka Mäkelä.   

Abstract

The objectives of this prospective epidemiological study were to describe the diagnosis and treatment of respiratory tract infections by Finnish general practitioners and to compare current practice with national evidence-based guidelines. All patients (n = 4386) seeking primary care for a respiratory tract infection for the first time in 30 health centres during 1 week in November 1998 participated in the study. The main outcome measures were the amounts and types of diagnostic tests used and antimicrobials prescribed. Tympanometry was used in 1% of patients with acute otitis media. Ultrasonography, sinus radiography or both were used in 80% of cases of sinusitis and antigen detection or culture for Streptococci in 57% of throat infections. In acute bronchitis, a chest radiograph was taken in 5% of cases and the CRP level determined in 8%. The corresponding figures for pneumonia were 49% and 39%. In pneumonia and throat infection, diagnostic testing was statistically significantly associated with the use of antimicrobials, but not in otitis, sinusitis or acute bronchitis. Diagnostic tests were underused in respiratory tract infections compared to evidence-based recommendations.

Entities:  

Mesh:

Year:  2002        PMID: 12578153     DOI: 10.1080/0036554021000026939

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  The course of C-reactive protein response in untreated upper respiratory tract infection.

Authors:  Hasse Melbye; Dag Hvidsten; Arne Holm; Sveine Arne Nordbø; Jan Brox
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

2.  Integrated DNA and RNA extraction using magnetic beads from viral pathogens causing acute respiratory infections.

Authors:  Hui He; Rongqun Li; Yi Chen; Ping Pan; Wenjuan Tong; Xueyan Dong; Yueming Chen; Daojun Yu
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.